Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 27

Sort by

Sort Order Select

Meeting Abstracts

424-P: Body-Weight Variability and Risk of Cardiovascular Outcomes in Type 1 Diabetes: Results from the DCCT/EDIC Studies

IULIA PETRIA, SAMUEL ALBUQUERQUE, GAEL VAROQUAUX, JILL-JÊNN VIE, GILBERTO VELHO, GIANLUCA PERSEGHIN, RONAN ROUSSEL, LOUIS POTIER

Diabetes 2022;71(Supplement_1):424-P

https://doi.org/10.2337/db22-424-P

Published: 01 June 2022

View articletitled, 424-P: Body-Weight Variability and Risk of Cardiovascular Outcomes in Type 1 Diabetes: Results from the DCCT/EDIC Studies

Meeting Abstracts

323-OR: Associations of Leukocyte Telomere Length and Related Allelic Variations with the Risk of Coronary Events in People with Long-Standing Type 1 Diabetes

MANUEL SANCHEZ, LOUIS POTIER, NICOLAS VENTECLEF, FRÉDÉRIC FUMERON, ANDRÉ SCHEEN, JEAN-FRANÇOIS GAUTIER, MICHEL MARRE, RONAN ROUSSEL, KAMEL MOHAMMEDI, GILBERTO VELHO

Diabetes 2022;71(Supplement_1):323-OR

https://doi.org/10.2337/db22-323-OR

Published: 01 June 2022

View articletitled, 323-OR: Associations of Leukocyte Telomere Length and Related Allelic Variations with the Risk of Coronary Events in People with Long-Standing Type 1 Diabetes

Meeting Abstracts

421-P: Differential Prognostic Burden of Lower-Limb Amputation and Cardiovascular Disease on the Risk of All-Cause Death in People with Type 1 Diabetes

MARION CAMOIN, GILBERTO VELHO, PIERRE-JEAN SAULNIER, LOUIS POTIER, YAWA ABOULEKA, CHARLYNE CARPENTIER, SEVERINE DUBOIS, ALICE LARROUMET, VINCENT RIGALLEAU, OLIVIER BOURRON, ANDRÉ SCHEEN, RONAN ROUSSEL, MICHEL MARRE, KAMEL MOHAMMEDI

Diabetes 2022;71(Supplement_1):421-P

https://doi.org/10.2337/db22-421-P

Published: 01 June 2022

View articletitled, 421-P: Differential Prognostic Burden of Lower-Limb Amputation and Cardiovascular Disease on the Risk of All-Cause Death in People with Type 1 Diabetes

Meeting Abstracts

1799-P: Insulin Secretion during a Graded Glucose Infusion Correlates with GPS2 mRNA Expression in Adipocytes

GILBERTO VELHO, KARIMA DRARENI, JEAN-LOUIS NGUEWA, RONAN ROUSSEL, JEAN-PIERRE RIVELINE, NICOLAS VENTECLEF, JEAN-FRANÇOIS GAUTIER

Diabetes 2020;69(Supplement_1):1799-P

https://doi.org/10.2337/db20-1799-P

Published: 01 June 2020

View articletitled, 1799-P: Insulin Secretion during a Graded Glucose Infusion Correlates with GPS2 mRNA Expression in Adipocytes

Meeting Abstracts

220-OR: Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Risk for Lower Extremity Amputation in People with Type 2 Diabetes

LOUIS POTIER, RONAN ROUSSEL, PIERRE-JEAN SAULNIER, FRÉDÉRIC FUMERON, KAMEL MOHAMMEDI, GILBERTO VELHO

Diabetes 2020;69(Supplement_1):220-OR

https://doi.org/10.2337/db20-220-OR

Published: 01 June 2020

View articletitled, 220-OR: Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Risk for Lower Extremity Amputation in People with Type 2 Diabetes

Meeting Abstracts

68-OR: Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study

RONAN ROUSSEL, BRUNO GUERCI, ERIC VICAUT, GERARD DEPOUVOURVILLE, BRUNO DETOURNAY, CORINNE EMERY, FLEUR LEVRAT-GUILLEN, JEAN-PIERRE RIVELINE

Diabetes 2020;69(Supplement_1):68-OR

https://doi.org/10.2337/db20-68-OR

Published: 01 June 2020

View articletitled, 68-OR: Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study

Meeting Abstracts

67-OR: Plasma Copeptin and Risk for Lower Extremity Amputation in People with Type 1 and Type 2 Diabetes

LOUIS POTIER, RONAN ROUSSEL, KAMEL MOHAMMEDI, PIERRE SAULNIER, MICHEL MARRE, SAMY HADJADJ, GILBERTO VELHO

Diabetes 2019;68(Supplement_1):67-OR

https://doi.org/10.2337/db19-67-OR

Published: 01 June 2019

View articletitled, 67-OR: Plasma Copeptin and Risk for Lower Extremity Amputation in People with Type 1 and Type 2 Diabetes

Meeting Abstracts

629-P: Bedside Blind Bone Biopsy for Diagnosis of Diabetic Foot Osteitis Allows Similar Healing Rate as Conventional Bone Biopsy

FLORINE FÉRON, LOUIS POTIER, GAUTHIER PÉAN DE PONFILLY, DIANE-CÉ CILE GAUTHIER, ANNE-LISE MUNIER, EMMANUEL LECORCHE, NATHALIE GRALL, MARIE LALOI-MICHELIN, FREDERIC MERCIER, TIPHAINE VIDAL-TRÉCAN, MICHEL MARRE, JEAN-PIERRE RIVELINE, JEAN-FRANCOIS GAUTIER, RONAN ROUSSEL, JEAN-PHILIPPE KEVORKIAN

Diabetes 2019;68(Supplement_1):629-P

https://doi.org/10.2337/db19-629-P

Published: 01 June 2019

View articletitled, 629-P: Bedside Blind Bone Biopsy for Diagnosis of Diabetic Foot Osteitis Allows Similar Healing Rate as Conventional Bone Biopsy

Meeting Abstracts

1090-P: Reaching ADA Glycemic Targets without Hypoglycemia during Titration with Gla-300 and IDeg in T2DM: Exploratory Analyses from BRIGHT

RONAN ROUSSEL, JUAN P. FRIAS, JUKKA WESTERBACKA, ZSOLT BOSNYAK, LYDIE MELAS-MELT, LORI BERARD, ALICE Y. CHENG

Diabetes 2019;68(Supplement_1):1090-P

https://doi.org/10.2337/db19-1090-P

Published: 01 June 2019

View articletitled, 1090-P: Reaching ADA Glycemic Targets without Hypoglycemia during Titration with Gla-300 and IDeg in T2DM: Exploratory Analyses from BRIGHT

Meeting Abstracts

1091-P: Association between Mild and Severe Hypoglycemia in People with T1 and T2 Diabetes Enrolled in Randomized Controlled Trials for Assessing Insulin Therapy

RONAN ROUSSEL, ABDUL MOUTAIROU, JEAN-PIERRE RIVELINE, JEAN-FRANCOIS GAUTIER, LOUIS POTIER

Diabetes 2019;68(Supplement_1):1091-P

https://doi.org/10.2337/db19-1091-P

Published: 01 June 2019

View articletitled, 1091-P: Association between Mild and Severe Hypoglycemia in People with T1 and T2 Diabetes Enrolled in Randomized Controlled Trials for Assessing Insulin Therapy

Meeting Abstracts

431-P: Diabetic Retinopathy and Risk of Lower-Extremity Artery Disease in Type 2 Diabetes

NINON FOUSSARD, PIERRE SAULNIER, CAPUCINE BERTRAND, ELISE GAND, STEPHANIE RAGOT, LOUIS POTIER, GILBERTO VELHO, MICHEL MARRE, RONAN ROUSSEL, VINCENT RIGALLEAU, KAMEL MOHAMMEDI, SAMY HADJADJ

Diabetes 2019;68(Supplement_1):431-P

https://doi.org/10.2337/db19-431-P

Published: 01 June 2019

View articletitled, 431-P: Diabetic Retinopathy and Risk of Lower-Extremity Artery Disease in Type 2 Diabetes

Meeting Abstracts

535-P: Relationship between Renal Capacities to Reabsorb Glucose and Kidney Disease in Patients with Diabetes

ODETTE MATAR, LOUIS POTIER, YAWA ABOULEKA, FRÉDÉRIC FUMERON, KAMEL MOHAMMEDI, SAMY HADJADJ, RONAN ROUSSEL, GILBERTO VELHO, MICHEL MARRE

Diabetes 2019;68(Supplement_1):535-P

https://doi.org/10.2337/db19-535-P

Published: 01 June 2019

View articletitled, 535-P: Relationship between Renal Capacities to Reabsorb Glucose and Kidney Disease in Patients with Diabetes

Meeting Abstracts

550-P: Age at Diabetes Onset and Risk for Diabetic Kidney Disease

CHARLYNE CARPENTIER, SEVERINE DUBOIS, YAWA ABOULEKA, BEATRICE DULY-BOUHANICK, SAMY HADJADJ, REGIS COUTANT, RONAN ROUSSEL, GILBERTO VELHO, MICHEL MARRE

Diabetes 2019;68(Supplement_1):550-P

https://doi.org/10.2337/db19-550-P

Published: 01 June 2019

View articletitled, 550-P: Age at Diabetes Onset and Risk for Diabetic Kidney Disease

Meeting Abstracts

Similar Glycemic Control and Less or Comparable Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (IDeg-100) in Insulin-Naïve T2DM on Antihyperglycemic Drugs ± GLP-1 RAs—The BRIGHT Randomized Study

ALICE Y.Y. CHENG, JULIO ROSENSTOCK, ROBERT RITZEL, ZSOLT BOSNYAK, CHRISTINE DEVISME, PETER STELLA, ANNA M. CALI, XIANGLING WANG, JUAN P. FRIAS, RONAN ROUSSEL, GEREMIA B. BOLLI

Diabetes 2018;67(Supplement_1):301-OR

https://doi.org/10.2337/db18-301-OR

Published: 01 July 2018

View articletitled, Similar Glycemic Control and Less or Comparable Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (IDeg-100) in Insulin-Naïve T2DM on Antihyperglycemic Drugs ± GLP-1 RAs—The BRIGHT Randomized Study

Meeting Abstracts

Association of Diuretics Use and Amputations in Patients with Type 2 Diabetes—A Hypothesis Driven from Canvas Warning?

LOUIS POTIER, KAMEL MOHAMMEDI, ABDUL K. MOUTAIROU, ANISOARA BUMBU, ODETTE MATAR, FABRICE SCHNEIDER, MICHEL MARRE, PIERRE SAULNIER, GILBERTO VELHO, RONAN ROUSSEL, SAMY HADJADJ

Diabetes 2018;67(Supplement_1):2221-PUB

https://doi.org/10.2337/db18-2221-PUB

Published: 01 July 2018

View articletitled, Association of Diuretics Use and Amputations in Patients with Type 2 Diabetes—A Hypothesis Driven from Canvas Warning?

Meeting Abstracts

Prognostic Values of Inflammation and Oxidative Stress Biomarkers on the Risk of Peripheral Arterial Disease in Type 2 Diabetes

MATHILDE NATIVEL, FABRICE SCHNEIDER, PIERRE SAULNIER, OLIVIER MEILHAC, PHILIPPE RONDEAU, MAXIME COURNOT, LOUIS POTIER, GILBERTO VELHO, MICHEL MARRE, RONAN ROUSSEL, VINCENT RIGALLEAU, KAMEL MOHAMMEDI, SAMY HADJADJ

Diabetes 2018;67(Supplement_1):2220-PUB

https://doi.org/10.2337/db18-2220-PUB

Published: 01 July 2018

View articletitled, Prognostic Values of Inflammation and Oxidative Stress Biomarkers on the Risk of Peripheral Arterial Disease in Type 2 Diabetes

Meeting Abstracts

Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus

RONAN ROUSSEL, SANTIAGO DURAN-GARCIA, YILONG ZHANG, SUNERI SHAH, CAROLYN DARMIENTO, R. RAVI SHANKAR, EDWARD A. O'NEILL, GREGORY T. GOLM, RAYMOND L. LAM, IRA GANTZ, KEITH D. KAUFMAN, SAMUEL S. ENGEL

Diabetes 2018;67(Supplement_1):112-LB

https://doi.org/10.2337/db18-112-LB

Published: 01 July 2018

View articletitled, Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus

Meeting Abstracts

Lower Hypoglycemia Rates with Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve Adults with T2DM on Oral Antihyperglycemic Therapy ± GLP-1RA—The BRIGHT Randomized Study

GEREMIA B. BOLLI, ALICE CHENG, ZSOLT BOSNYAK, EMMANUELLE BOELLE-LE CORFEC, ANNA M. CALI, XIANGLING WANG, JUAN P. FRIAS, RONAN ROUSSEL, JULIO ROSENSTOCK

Diabetes 2018;67(Supplement_1):1032-P

https://doi.org/10.2337/db18-1032-P

Published: 01 July 2018

View articletitled, Lower Hypoglycemia Rates with Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve Adults with T2DM on Oral Antihyperglycemic Therapy ± GLP-1RA—The BRIGHT Randomized Study

Meeting Abstracts

Impact of Background Antihyperglycemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with T2DM from the BRIGHT Randomized Study

RONAN ROUSSEL, JULIO ROSENSTOCK, JEREMY PETTUS, ROBERT RITZEL, ALICE CHENG, ZSOLT BOSNYAK, CHRISTINE DEVISME, ANNA M. CALI, XIANGLING WANG, GEREMIA B. BOLLI

Diabetes 2018;67(Supplement_1):1029-P

https://doi.org/10.2337/db18-1029-P

Published: 01 July 2018

View articletitled, Impact of Background Antihyperglycemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with T2DM from the BRIGHT Randomized Study

Meeting Abstracts

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

SEAN D. SULLIVAN, TIMOTHY S. BAILEY, RONAN ROUSSEL, FANG L. ZHOU, ZSOLT BOSNYAK, RON PREBLICK, JUKKA WESTERBACKA, RISHAB GUPTA, LAWRENCE BLONDE

Diabetes 2018;67(Supplement_1):1056-P

https://doi.org/10.2337/db18-1056-P

Published: 01 July 2018

View articletitled, Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

Update search

NARROW

Format

Journal

Article Type

Topics

Issue Section

Date

Availability

424-P: Body-Weight Variability and Risk of Cardiovascular Outcomes in Type 1 Diabetes: Results from the DCCT/EDIC Studies

323-OR: Associations of Leukocyte Telomere Length and Related Allelic Variations with the Risk of Coronary Events in People with Long-Standing Type 1 Diabetes

421-P: Differential Prognostic Burden of Lower-Limb Amputation and Cardiovascular Disease on the Risk of All-Cause Death in People with Type 1 Diabetes

1799-P: Insulin Secretion during a Graded Glucose Infusion Correlates with GPS2 mRNA Expression in Adipocytes

220-OR: Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Risk for Lower Extremity Amputation in People with Type 2 Diabetes

68-OR: Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study

67-OR: Plasma Copeptin and Risk for Lower Extremity Amputation in People with Type 1 and Type 2 Diabetes

629-P: Bedside Blind Bone Biopsy for Diagnosis of Diabetic Foot Osteitis Allows Similar Healing Rate as Conventional Bone Biopsy

1090-P: Reaching ADA Glycemic Targets without Hypoglycemia during Titration with Gla-300 and IDeg in T2DM: Exploratory Analyses from BRIGHT

1091-P: Association between Mild and Severe Hypoglycemia in People with T1 and T2 Diabetes Enrolled in Randomized Controlled Trials for Assessing Insulin Therapy

431-P: Diabetic Retinopathy and Risk of Lower-Extremity Artery Disease in Type 2 Diabetes

535-P: Relationship between Renal Capacities to Reabsorb Glucose and Kidney Disease in Patients with Diabetes

550-P: Age at Diabetes Onset and Risk for Diabetic Kidney Disease

Similar Glycemic Control and Less or Comparable Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (IDeg-100) in Insulin-Naïve T2DM on Antihyperglycemic Drugs ± GLP-1 RAs—The BRIGHT Randomized Study

Association of Diuretics Use and Amputations in Patients with Type 2 Diabetes—A Hypothesis Driven from Canvas Warning?

Prognostic Values of Inflammation and Oxidative Stress Biomarkers on the Risk of Peripheral Arterial Disease in Type 2 Diabetes

Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus

Lower Hypoglycemia Rates with Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve Adults with T2DM on Oral Antihyperglycemic Therapy ± GLP-1RA—The BRIGHT Randomized Study

Impact of Background Antihyperglycemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with T2DM from the BRIGHT Randomized Study

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only